SUJAY KANGO Insider Trading
Get free email notifications about insider trading for SUJAY KANGO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SUJAY KANGO. SUJAY KANGO is a Chief Commercial Officer in INFINITY PHARMACEUTICALS, INC. ($INFI) and a EVP, Chief Commercial Officer in ACCELERON PHARMA INC ($XLRN) and a SVP, Chief Commercial Officer in ACCELERON PHARMA INC ($XLRN).
Address: 1028 CHAMBERS COURT BRIDGEWATER 08807 NJ
Companies in which SUJAY KANGO is an Insider
ACCELERON PHARMA INC
Trading Symbol: XLRNIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of SUJAY KANGO: EVP, Chief Commercial Officer, SVP, Chief Commercial Officer
Holdings: 24,396 shares
Current Value: $579,161
Latest Transaction: Mar 04 2021
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INFINITY PHARMACEUTICALS, INC.
Trading Symbol: INFIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SUJAY KANGO: Chief Commercial Officer
Holdings: 50,590 shares
Current Value: $118,887
Latest Transaction: Dec 14 2016
$INFI Market Capitalization: $115.87M
$INFI Previous Close: $2.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of SUJAY KANGO
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 04 2021 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | EVP, Chief Commerci ... | Option Exercise | M | 40.61 | 5,000 | 203,050 | 35,000 | |
Mar 04 2021 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | EVP, Chief Commerci ... | Sell | S | 138.15 | 200 | 27,630 | 19,396 | 19.6 K to 19.4 K (-1.02 %) |
Mar 04 2021 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | EVP, Chief Commerci ... | Sell | S | 137.12 | 600 | 82,272 | 19,596 | 20.2 K to 19.6 K (-2.97 %) |
Mar 04 2021 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | EVP, Chief Commerci ... | Sell | S | 136.24 | 1,501 | 204,496 | 20,196 | 21.7 K to 20.2 K (-6.92 %) |
Mar 04 2021 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | EVP, Chief Commerci ... | Sell | S | 135.48 | 2,699 | 365,661 | 21,697 | 24.4 K to 21.7 K (-11.06 %) |
Mar 04 2021 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | EVP, Chief Commerci ... | Buy | M | 40.61 | 5,000 | 203,050 | 24,396 | 19.4 K to 24.4 K (+25.78 %) |
Feb 02 2021 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | EVP, Chief Commerci ... | Option Exercise | A | 115.53 | 20,896 | 2,414,115 | 20,896 |